These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 370341)

  • 1. Phenotypic resistance to amphotericin B in Candida albicans: the role of reduction.
    Gale EF; Johnson AM; Kerridge D; Miles EA
    J Gen Microbiol; 1978 Dec; 109(2):191-204. PubMed ID: 370341
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth.
    Gale EF; Johnson AM; Kerridge D; Koh TY
    J Gen Microbiol; 1975 Mar; 87(1):20-36. PubMed ID: 1094096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic resistance to amphotericin B in Candida albicans: relationship to glucan metabolism.
    Notario V; Gale EF; Kerridge D; Wayman F
    J Gen Microbiol; 1982 Apr; 128(4):761-77. PubMed ID: 6126520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic resistance to miconazole and amphotericin B in Candida albicans.
    Gale EF; Johnson AM; Kerridge D; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):535-8. PubMed ID: 6999120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of Candida albicans cell and protoplast sensitivity to polyene antibiotics].
    Virina AM; Belousova II; Tereshin IM
    Mikrobiologiia; 1980; 49(1):54-8. PubMed ID: 6993877
    [No Abstract]   [Full Text] [Related]  

  • 6. Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients.
    Stieritz DD; Law EJ; Holder IA
    J Clin Pathol; 1973 Jun; 26(6):405-8. PubMed ID: 4578160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature and development of phenotypic resistance to amphotericin B in Candida albicans.
    Gale EF
    Adv Microb Physiol; 1986; 27():277-320. PubMed ID: 3532717
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of aeration and metabolic inhibitors on resistance to amphotericin in starved cultures of Candida albicans.
    Gale EF; Johnson AM; Kerridge D
    J Gen Microbiol; 1977 Mar; 99(1):77-84. PubMed ID: 325178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B.
    Collins MS; Pappagianis D
    Sabouraudia; 1974 Nov; 12(3):329-40. PubMed ID: 4610825
    [No Abstract]   [Full Text] [Related]  

  • 10. The porosity of the cell wall of Candida albicans.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):253-5. PubMed ID: 6997435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Candida albicans by amphotericin B in combination with 5-fluorocytosine.
    Beggs WH; Sarosi GA; Andrews FA
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):559-62. PubMed ID: 4604617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Composition and certain properties of Candida albicans cells with a low level of resistance to polyene antibiotics].
    Virina AM; Feĭgin AM; Belousova II; Tereshin IM
    Mikrobiologiia; 1979; 48(5):838-44. PubMed ID: 388159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
    Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H
    Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.
    Johnson B; White RJ; Williamson GM
    J Gen Microbiol; 1978 Feb; 104(2):325-33. PubMed ID: 24676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a polyene antibiotic on growth and phosphate uptake by Candida albicans.
    Berdicevsky I; Grossowicz N
    J Gen Microbiol; 1977 Oct; 102(2):299-304. PubMed ID: 336844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment with enzymes.
    Gale EF; Ingram J; Kerridge D; Notario V; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):383-91. PubMed ID: 6999116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
    O'Keeffe J; Kavanagh K
    Anticancer Res; 2004; 24(2A):405-8. PubMed ID: 15152937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of TNF-alpha and IL-6 from human monocytes stimulated by filtrates of Candida albicans after treatment with amphotericin B.
    Ghezzi MC; Raponi G; Filadoro F; Mancini C
    J Antimicrob Chemother; 1994 May; 33(5):1039-43. PubMed ID: 8089051
    [No Abstract]   [Full Text] [Related]  

  • 19. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
    Geraghty P; Kavanagh K
    Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans.
    Geraghty P; Kavanagh K
    J Pharm Pharmacol; 2003 Feb; 55(2):179-84. PubMed ID: 12631409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.